RNAi Technology Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 11
SKU : BT2276
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the RNAi Technology Market?
RNAi Technology Market is expected to grow at a CAGR of 10.3% during the forecast period 2024-2031.
Who are the key players in the RNAi Technology Market?
The major global players in the RNAi technology market include Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics, Phio Pharmaceuticals, Benitec Biopharma, Novartis AG, AstraZeneca, Silence Therapeutics, Arbutus Biopharma and Sylentis S.A. among others.
Related Reports
biotechnologyClinical Microbiology Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
biotechnologySingle-Use Bioprocessing Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
biotechnologyProtein Detection Quantification Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
biotechnologyMetagenomic Sequencing Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
biotechnologyBiodigester Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
biotechnologySingle Use Assemblies Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
Starting from
$4350